Rafał Dziadziuszko - Publications, H-index & Citations

Rafał Dziadziuszko

medical university of gdansk

59H指数

603论文数

1.8W被引数

收录论文 145

发表时间

Adjuvant alectinib versus chemotherapy in resected ALK- positive non-small-cell lung cancer (ALINA): health-related quality-of-life and safety outcomes from a randomised, open-label, phase 3 trial 辅助阿来替尼与化疗在切除后的ALK阳性非小细胞肺癌（ALINA）：一项随机、开放标签、III期试验的健康相关生活质量与安全性结果

Lancet Oncology

IF35.9

2026-08-01

PREAI

Dziadziuszko, Rafal; Ahn, Jin Seok; Barlesi, Fabrice; Solomon, Benjamin J.; Wu, Yi-Long; Bondarenko, Igor; Hochmair, Maximilian; Horinouchi, Hidehito; Lee, Dae Ho; Lee, Jong-Seok; Planchard, David; Rittmeyer, Achim; Zhong, Wenzhao; Adler, Leah; Archer, Venice; Cardona, Andres; Petric, Patricia; Scalori, Astrid; Ding, Beiying; Mamolo, Carla; Smoljanovic, Vlatka; Nishio, Makoto

Prognostic Role of 18F-FDG PET/CT in Oligometastatic Non-Small Cell Lung Cancer: Preliminary Results from Single Center 18F-FDG PET/CT在寡转移性非小细胞肺癌中的预后作用：单中心初步结果

Cancers

IF4.4

2026-06-09

OAAI

Artur Bandura; Monika Mierzejewska; Wojciech Cytawa; Rafał Dziadziuszko

PP01.07/OA06.01: Validation of ‘KEAP-ness’ 12-gene Expression Signature as a Prognostic Biomarker in Early-Stage Surgically Treated Lung Cancer PP01.07/OA06.01: 验证“KEAP-ness”12基因表达谱作为早期手术治疗肺癌的预后生物标志物

Journal of Thoracic Oncology

IF20.8

2026-01-09

PREAI

Wiktor Lijewski; Krzysztof Pastuszak; Magdalena Lepszy; Julia Wojciechowska; Przemysław Miłosz; Jacek Kowalski; Tomasz Stokowy; Rafał Dziadziuszko; Witold Rzyman; Marcin Skrzypski

Plain language summary of the ALINA study results: alectinib compared with chemotherapy after surgery in people with ALK-positive non-small cell lung cancer ALINA研究结果的大众语言摘要：alectinib与化疗相比，在ALK阳性非小细胞肺癌患者术后的应用

Future Science OA

IF2.1

2025-12-31

PREAI

Wu, Yi-Long; Dziadziuszko, Rafal; Ahn, Jin Seok; Barlesi, Fabrice; Nishio, Makoto; Lee, Dae Ho; Lee, Jong-Seok; Zhong, Wenzhao; Horinouchi, Hidehito; Mao, Weimin; Hochmair, Maximilian; De Marinis, Filippo; Migliorino, Maria Rita; Bondarenko, Igor; Lu, Shun; Wang, Qun; Lohmann, Tania Ochi; Xu, Tingting; Cardona, Andres; Hiles, Laura; Noe, Johannes; Solomon, Benjamin J.

Early Artificial Urinary Sphincter Implantation Prior to Salvage Radiotherapy: A Feasibility and Dosimetric Analysis 早期人工尿道括约肌植入术在挽救性放射治疗前的应用：一项可行性与剂量学分析

Urology

IF2

2025-12-01

PREAI

Frankiewicz, Mikolaj; Matuszewska, Katarzyna; Dziadziuszko, Rafal; Matuszewski, Marcin

MAGELLAN arms B1 and B3: Durvalumab plus chemotherapy with and without oleclumab in treatment-naïve metastatic non-small-cell lung cancer MAGELLAN方案B1和B3臂：在治疗初治转移性非小细胞肺癌患者中，比较度伐利尤单抗联合化疗与联合化疗并联合奥雷oclumab的疗效。

Lung Cancer

IF4.4

2025-11-07

PREAI

Byoung Chul Cho; Chaiyut Charoentum; Dong-Wan Kim; Cheng-Ta Yang; Rafal Dziadziuszko; Sarayut Lucien Geater; Helen Mann; Banafsheh Afshar-Imani; Pavlo Lyfar; James Chih-Hsin Yang; Sandip Pravin Patel

\zaAlectinib versus crizotinib in previously untreated ALK-positive advanced non-small cell lung cancer: Final overall survival analysis of the Phase III ALEX study 阿来替尼对比克唑替尼用于初治ALK阳性晚期非小细胞肺癌：III期ALEX研究最终总生存期分析

Annals of Oncology

IF65.4

2025-10-17

OAAI

S. Peters; R. Camidge; R. Dziadziuszko; S. Gadgeel; A.T. Shaw; D-W. Kim; M. Pérol; D.R. Rosell; P. Cheema; D.Wan-Teck Lim; J.J. Lin; N. Pavlakis; J.S. Ahn; L. Zhang; V. Henschel; A.A. Higgerson; V. McNally; I. Rooney; A. Scalori; V. Smoljanovic; T. Mok

Durvalumab after radiotherapy in patients with unresectable stage III non-small-cell lung cancer ineligible for chemotherapy: the DUART phase II nonrandomized controlled study☆度伐鲁单抗在不可切除的III期非小细胞肺癌且不符合化疗指征的患者放疗后的应用：DUART II期非随机对照研究☆

ESMO Open

IF8.3

2025-08-20

PREAI

A.R. Filippi; M.R. García Campelo; J.-B. Paoli; D. Kowalski; C. Bennati; P. Borghetti; D. Cortinovis; A. Delmonte; C. Genova; S. Van Hulst; R.M. Mroz; S. Nawrocki; I. Toledano; G. Tonini; F. Agustoni; G. Wetherill; Z. Zhu; I.D. Perez; K. Foroutanpour; N. Georgoulia; R. Dziadziuszko

Integrated transcriptomic and functional modeling reveals AKT and mTOR synergy in colorectal cancer 整合转录组学和功能建模揭示AKT和mTOR在结直肠癌中的协同作用

Scientific Reports

IF3.9

2025-07-31

OAAI

Marcin Duleba; Eliza Zimoląg; Joanna Szuszkiewicz; Marcin Serocki; Joanna Szklarczyk; Olga Dracz; Alexander Kurzejamski; Izabella Więckowska; Marcelina Chmiel; Barbara Lipert; Katarzyna Sarad; Joanna Krawczyk; Oleksii Bryzghalov; Agata Stachowicz-Wałaszek; Karolina Pyziak; Joanna Drozdowska; Krzysztof Baczyński; Konrad Wojtowicz; Maurycy Chronowski; Krzysztof Rataj; Magdalena Otrocka; Michał Mikula; Paula Feliksiak; Rafał Dziadziuszko; Tomasz Rzymski; Andrew Thomason; Krzysztof Brzózka; Andrzej Mazan

Intracranial activity of sotorasib vs docetaxel in pretreated KRAS G12C-mutated advanced non-small cell lung cancer from a global, phase 3, randomized controlled trial 索托拉西布与多西他赛在经治KRAS G12C突变型晚期非小细胞肺癌中的颅内活性比较：一项全球性、III期、随机对照试验

Lung Cancer

IF4.4

2025-07-29

OAAI

Anne-Marie C. Dingemans; Konstantinos Syrigos; Lorenzo Livi; Astrid Paulus; Sang-We Kim; Yuanbin Chen; Enriqueta Felip; Frank Griesinger; Kadoaki Ohashi; Gerard Zalcman; Brett G.M. Hughes; Jens Benn Sørensen; Normand Blais; Carlos G.M. Ferreira; Colin R. Lindsay; Rafal Dziadziuszko; Patrick J. Ward; Cynthia Chinedu Obiozor; Yang Wang; Solange Peters

A plasma 9-microRNA signature for lung cancer early detection: a multicenter analysis 一种用于肺癌早期检测的血浆9-microRNA特征：一项多中心分析

BIOMARKER RESEARCH

IF11.5

2025-05-16

OAAI

Dama, Elisa; Colangelo, Tommaso; Cuttano, Roberto; Dziadziuszko, Rafal; Dandekar, Thomas; Widlak, Piotr; Rzyman, Witold; Veronesi, Giulia; Bianchi, Fabrizio

Stereotactic body radiotherapy plus neoadjuvant chemoimmunotherapy in operable non-small-cell lung cancer

LANCET RESPIRATORY MEDICINE

IF32.8

2024-12-01

PREAI

Dziadziuszko, Rafal; Tomasik, Bartlomiej

Lung cancer research and treatment: global perspectives and strategic calls to action 肺癌研究与治疗: 全球视角与战略行动呼吁

ANNALS OF ONCOLOGY

IF65.4

2024-12-01

PREAI

Meyer, M. -l.; Peters, S.; Mok, T. S.; Lam, S.; Yang, P. -c.; Aggarwal, C.; Brahmer, J.; Dziadziuszko, R.; Felip, E.; Ferris, A.; Forde, P. M.; Gray, J.; Gros, L.; Halmos, B.; Herbst, R.; Jaenne, P. A.; Johnson, B. E.; Kelly, K.; Leighl, N. B.; Liu, S.; Lowy, I.; Marron, T. U.; Paz-Ares, L.; Rizvi, N.; Rudin, C. M.; Shum, E.; Stahel, R.; Trunova, N.; Bunn, P. A.; Hirsch, F. R.

Whole exome sequencing (WES) analyses from IMpower133 and 6-year (y) overall survival (OS) from IMbrella A in patients (pts) with extensive-stage small cell lung cancer (ESSCLC) treated with atezolizumab (atezo)全外显子组测序(WES)分析来自IMpower133和IMbrella A研究6年(y)总生存期(OS)的数据，来自接受阿替利珠单抗(atezo)治疗的广泛期小细胞肺癌(ESSCLC)患者(pts)。

ANNALS OF ONCOLOGY

IF65.4

2024-12-01

PREAI

Kao, S. C-H.; Reck, M.; Liu, S. V.; Dziadziuszko, R.; Hochmair, M. J.; Huemer, F.; Gilberto de Castro, J.; Bernabe Caro, R.; Kim, S. H.; Kowalski, D. M.; Andric, Z. G.; Oancea, M.; Kaul, M.; Li, H.; Danner, B.; Lee, M. C.; Nabet, B. Y.; Sugawara, S.

Plain language summary: tarlatamab for patients with previously treated small cell lung cancer

FUTURE ONCOLOGY

IF2.6

2024-11-12

OAAI

Ahn, Myung-Ju; Cho, Byoung Chul; Felip, Enriqueta; Korantzis, Ippokratis; Ohashi, Kadoaki; Majem, Margarita; Juan-Vidal, Oscar; Handzhiev, Sabin; Izumi, Hiroki; Lee, Jong-Seok; Dziadziuszko, Rafal; Wolf, Juergen; Blackhall, Fiona; Reck, Martin; Alvarez, Jean Bustamante; Hummel, Horst-Dieter; Dingemans, Anne-Marie C.; Sands, Jacob; Akamatsu, Hiroaki; Owonikoko, Taofeek K.; Ramalingam, Suresh S.; Borghaei, Hossein; Johnson, Melissa L.; Huang, Shuang; Mukherjee, Sujoy; Minocha, Mukul; Jiang, Tony; Martinez, Pablo; Anderson, Erik S.; Paz-Ares, Luis

Phase 2 study of the antitumour activity and safety of simlukafusp alfa (FAP-IL2v) combined with atezolizumab in patients with recurrent and/or metastatic cervical squamous cell carcinoma simlukafusp alfa (FAP-IL2v) 联合阿特珠单抗治疗复发和/或转移性宫颈鳞状细胞癌患者的抗肿瘤活性和安全性的2期研究

EBIOMEDICINE

IF10.8

2024-11-01

PREAI

Verlingue, Loic; Italiano, Antoine; Prenen, Hans; Alia, Eva Maria Guerra; Tosi, Diego; Perets, Ruth; Lugowska, Iwona; Moiseyenko, Vladimir; Gumus, Mahmut; Arslan, Cagatay; Lindsay, Colin R.; Deva, Sanjeev; Taus, Alvaro; Oaknin, Ana; Rottey, Sylvie; Cicin, Irfan; Goksu, Sema Sezgin; Smolin, Alexey; Rosello-Keranen, Susana; Habigt, Christin; Marbach, Daniel; Boetsch, Christophe; Dejardin, David; Sleiman, Nassim; Evers, Stefan; Richard, Muriel; Ardeshir, Caroline; Charo, Jehad; Kraxner, Anton; Teichgraber, Volker; Keshelava, Nino; Dziadziuszkoz, Rafal

Exploring Synthetic Lethality and novel drug combinations in Patient-Derived Cells

EUROPEAN JOURNAL OF CANCER

IF7.1

2024-10-01

PREAI

Duleba, M.; Zimolag, E.; Szuszkiewicz, J.; Serocki, M.; Krawczyk, J.; Bryzghalov, O.; Stachowicz, A.; Wieckowska, I.; Chmiel, M.; Kurzejamski, A.; Lipert, B.; Wojtowicz, K.; Chronowski, M.; Otrocka, M.; Mikula, M.; Dziadziuszko, R.; Brzozka, K.; Rzymski, T.; Mazan, A.

Long-term follow-up of single-agent divarasib in patients with KRAS G12C-positive solid tumors 单药divarasib在KRAS G12C阳性实体瘤患者中的长期随访研究

ANNALS OF ONCOLOGY

IF65.4

2024-09-01

PREAI

Garralda, E.; Patel, M. R.; Kim, T. W.; Sacher, A. G.; Forster, M. D.; Santoro, A.; Desai, J.; Paz-Ares, L. G.; Falcon Gonzalez, A.; De Miguel, M.; Bowyer, S. E.; Dziadziuszko, R.; Kim, S. H.; Han, S-W.; Krebs, M. G.; Lorusso, P.; Cosman, R.; Chang, J.; Jun, T.; Miller, W. H.

BMS-986012 (anti-fucosyl-monosialoganglioside-1 [fuc-GM1]) with carboplatin plus etoposide plus nivolumab (CE/NIVO) as first-line (1L) therapy in extensive-stage small cell lung cancer (ES-SCLC): Interim analysis (IA) of a randomized phase II study BMS-986012（抗岩藻糖基单唾液酸神经节苷脂-1[fuc-GM1]）联合卡铂、依托泊苷和纳武利尤单抗（CE/NIVO）作为广泛期小细胞肺癌（ES-SCLC）的一线（1L）疗法：一项随机Ⅱ期研究的期中分析（IA）

ANNALS OF ONCOLOGY

IF65.4

2024-09-01

PREAI

Kalinka, E.; Bahce, I.; Navarro Mendivil, A. F.; Ready, N.; Chu, Q. S-C.; Sugawara, S.; Sibille, A.; Provencio Pulla, M.; Johnson, M. L.; Hiltermann, J. T. J. N.; Ciuleanu, T-E.; Dziadziuszko, R.; Santo, A.; Zhang, Y.; Liu, Y.; Sarmiento, R.; Tannenbaum-Dvir, S.; Ojalvo, L.; Wu, J.; O'Byrne, K. J.

ALINA: Exploratory biomarker analyses in patients (pts) with resected ALK plus non-small cell lung cancer (NSCLC) treated with adjuvant alectinib vs chemotherapy (chemo)ALINA：在接受了手术切除的ALK阳性非小细胞肺癌（NSCLC）患者中，接受辅助阿来替尼治疗与接受化疗的患者的探索性生物标志物分析

ANNALS OF ONCOLOGY

IF65.4

2024-09-01

PREAI

Solomon, B. J.; Wu, Y-L.; Dziadziuszko, R.; Barlesi, F.; Nishio, M.; Ahn, J. S.; Horinouchi, H.; Hochmair, M. J.; de Marinis, F.; Migliorino, M. R.; Kurochkin, A.; Harputluoglu, H.; Planchard, D.; Korphaisarn, K.; Han, J-Y.; Lohmann, T.; Gavaldon, A. Cardona; Archer, V. R.; Nowicka, M.; Noe, J.

研究方向